Bio-reference Labs (BRLI) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts BRLI Hot Sheet
Price: $4.70 --0%
Financial Fact:
Depreciation and Amortization: 5.09M
Today's EPS Names:
PFBX, GOVB, VABK, More
Financial Fact:
Depreciation and Amortization: 5.09M
Today's EPS Names:
PFBX, GOVB, VABK, More
Join SI Premium – FREE
Bio-reference Labs (NASDAQ: BRLI) reported Q2 EPS of $0.33, $0.01 better than the analyst estimate of $0.32. Revenue for the quarter came in at $163.4 million versus the consensus estimate of $161.48 million.
For earnings history and earnings-related data on Bio-reference Labs (BRLI) click here.
For earnings history and earnings-related data on Bio-reference Labs (BRLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SPS Commerce (SPSC) Tops Q3 EPS by 16c; Offers Guidance
- Bayfirst Financial Corp (BAFN) Tops Q3 EPS by 4c
- Chain Bridge Bancorp, Inc. (CBNA) Tops Q3 EPS by 166c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
